Disclosures: David Twitchell: Nothing to Disclose, Dakota Bigham: Nothing to Disclose, Rodolfo Singleterry: Nothing to Disclose, Owais Syed: Nothing to Disclose, Eugenia Tsai: Nothing to Disclose, Fabian Rodas: Nothing to Disclose, Carmen Landaverde: Nothing to Disclose, Jan Petrasek: Nothing to Disclose, Eric Lawitz: Nothing to Disclose, Andres Gomez-Aldana: Nothing to Disclose, Emma Pham: Nothing to Disclose, Amanda Matthews: Nothing to Disclose, Jamiel Ramos: Nothing to Disclose, Kelly Velasquez: Nothing to Disclose, ELIZABETH CALDERA: Nothing to Disclose, Jonathan Inskeep: Nothing to Disclose, Clarissa Vaughn: Nothing to Disclose, Lisa Pedicone: Nothing to Disclose, Fred Poordad: Nothing to Disclose 497 AVOIDING PHLEBOTOMY ENTIRELY: VALIDATION OF A POINT-OF-CARE MEASURE OF APRI & FIB4 FROM FINGER-PRICK BLOOD David Smookler 1 Sarah Tran 2 Bethany Barber 2 Ahreni Saunthar 2 Magdalena Kuczynski 2 Andrew Mendlowitz 2 Aaron Vanderhoff 2 Mia Biondi 2 Camelia Capraru 2 Jordan Feld 3 , 1 Toronto Centre for Liver Disease, 2 VIRCAN/Toronto Centre for Liver Disease, 3 Toronto General Hospital Background: Achieving the World Health Organizations viral hepatitis elimination goals requires decentralized treatment
Pharmacological inhibition of FSP1 by iFSP1 4 also diminished the protective effects of phylloquinone and MK4 against ferroptosis induced by RSL3 and by genetic deletion of GPX4 (Fig
Omega-3 fatty acids, particularly EPA and DHA and their derivatives, such as resolvins, maresins, and protectins, can stimulate the cessation of inflammation by acting on immune cells
Take it on an empty stomach in the morning
Surgical & Cosmetic Dermatology
